United Therapeutics Corporation

符号: UTHR

NASDAQ

258.13

USD

今天的市场价格

11.5489
市盈率
-0.0982
PEG比率
11.45B
MRK市值
0.00%
DIV收益率

United Therapeutics Corporation (UTHR) 财务报表

Q: 什么是 United Therapeutics Corporation (UTHR) 总资产是多少？

United Therapeutics Corporation (UTHR) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 United Therapeutics Corporation (UTHR). 的默认数据。公司收入显示 818.108 M 的平均值，即 0.791 % 增长率。整个期间的平均毛利润为 745.38 M，即 -0.009 %. 平均毛利率为 0.726 %. 公司去年的净收入增长率为 0.354 %，等于 0.496 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 United Therapeutics Corporation 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.186. 在流动资产领域，UTHR 的报告货币为3551. 这些资产中的很大一部分，即 2994.1 是现金和短期投资。与去年的数据相比，该部分的变化率为-0.279%. 公司的长期投资虽然不是其重点，但以报告货币计算的1909.8（如果有的话）为1909.8。这表明与上一报告期相比，45.100% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 300. 这一数字表明，-0.125% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 5984.8. 这方面的年同比变化率为 0.248%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为278.9，存货估值为 111.8，商誉估值为 33.7（如有. 无形资产总额（如果有）按 80.5 估值.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
balance-sheet.row.cash-and-short-term-investments	13884.5	2994.1	4154.9	3580.6	2984.6	2253.4	1858.5	1430.1	1050.8	953.8	695.5	688.5	479.2	403.5	627.1	229.5	236	290.1	227.7	125.5	82.8	68.6	122.7	56	215.4	51.6	6.8
balance-sheet.row.short-term-investments	9250.3	1786.4	1877.5	1035.9	1096.3	747.5	746.7	222.3	27.8	122	297.8	409.6	325.2	240.8	374.9	129.1	106.6	150.7	136.7	56.3	0.2	0	0	31.7	14.5	33.3	0
balance-sheet.row.net-receivables	1117.5	278.9	220.4	198.7	157.4	151.4	175.7	297.1	214.5	192.8	162.3	126.3	116.6	88.7	73.7	53.3	30.6	29.7	25.6	18.8	14.8	10.6	9.7	4.2	2.4	0.4	0.1
balance-sheet.row.inventory	439.6	111.8	102	93.8	86.5	93.4	101	107.9	100	81.3	66.9	47.8	37.3	46	35.5	26.4	14.4	13.2	12	11.3	8	8.1	7.2	6	2.9	0	0
balance-sheet.row.other-current-assets	5494.3	166.2	219.2	100.4	88.3	133.8	75.4	115.5	59.5	47.4	49.4	46.4	3.8	6.2	759.9	15.4	16.4	19.5	0.1	0.2	1.7	0.6	1.1	1.8	1.5	0.7	9.9
balance-sheet.row.total-current-assets	13472	3551	3380.3	2323.6	2167.2	1864.5	1768	1447.9	1424.8	1275.3	974.2	909	668.5	562.5	765.1	324.5	297.4	352.5	277.4	166.8	110.5	89.7	141.9	69	222.1	52.7	16.8
balance-sheet.row.property-plant-equipment-net	4050.5	1045.4	861.5	780.9	731.6	738.5	699.7	545.7	489.3	495.8	478.4	464.9	453.7	366	306	303.9	221.1	69.4	34.7	21.8	17.8	15.2	9.1	6.4	5.9	3.8	1.3
balance-sheet.row.goodwill	33.7	33.7	28	28	28	28	31.5	13.7	10.3	10.3	10.3	10.7	10.5	8.1	2.5	8.8	7.5	7.5	7.5	7.5	7.5	0	7.5	0	0	0	0
balance-sheet.row.intangible-assets	169.4	80.5	16.5	16.6	130.1	130.3	139.3	31.9	23.5	18.1	19.2	3.4	5.9	14	7.4	9.7	0.4	1	3.1	13	13.4	13.9	14.5	15.4	17.5	2.7	0
balance-sheet.row.goodwill-and-intangible-assets	318.5	114.2	44.5	44.6	158.1	158.3	170.8	45.6	33.8	28.4	29.5	14.1	16.4	22.1	9.9	18.4	7.8	8.4	10.6	13	13.4	13.9	14.5	15.4	17.5	2.7	0
balance-sheet.row.long-term-investments	7486.1	1909.8	1316.2	1649.9	1149.6	767.5	442.6	502.7	2.3	38	122.8	453.5	311.1	349	138	188.6	146	9.7	36.4	44.9	46.2	0	10	116249	0	0	0
balance-sheet.row.tax-assets	1442.1	394.8	327.7	261.9	238.6	230	95.7	113.4	178.3	192.7	181.7	192.7	150.1	190.7	202.1	201	176	93.7	66.9	15.1	-46.2	0	-10	-116249	0	0	0
balance-sheet.row.other-non-current-assets	597.9	151.8	114.3	108.2	169.9	154.6	224.2	224.1	197.1	154.3	97.8	53.3	26.8	27.7	10.6	15.2	23	53.3	52.6	29.9	65.4	60.6	19.1	121.4	5	0.7	0.6
balance-sheet.row.total-non-current-assets	13895.1	3616	2664.2	2845.5	2447.8	2048.9	1633	1431.5	900.8	909.1	910.2	1178.6	958.1	955.6	666.6	727	573.9	234.6	201.2	124.7	96.7	89.8	42.7	143.1	28.5	7.2	1.9
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	27367.1	7167	6044.5	5169.1	4615	3913.4	3401	2879.4	2325.6	2184.4	1884.4	2087.6	1626.6	1518.1	1431.6	1051.5	871.3	587	478.6	291.4	207.2	179.5	184.6	212.1	250.6	59.9	18.7
balance-sheet.row.account-payables	631	5.6	4.1	3.8	4.1	9.9	23.1	8.4	8.1	7.5	7	6.7	10.2	47.3	16.1	18.8	20.3	2	3.1	4	6.1	4.3	3	6.7	6	2.3	1.7
balance-sheet.row.short-term-debt	700	400	0	0	0	250	0	0	0	5.4	126.5	282.5	0	0	236	220.3	0	250	0	0	0	0.8	0.1	0.1	0.1	0.1	0
balance-sheet.row.tax-payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	1800	300	800	800	800	600	250	250	0	0	0	3.7	275	194.2	68.9	30.3	279.2	0	250	0	0	0	1.8	1.8	1.8	1.8	0.3
Deferred Revenue Non Current	-42.4	-42.4	-41	-30	-27.4	-45.5	-53.3	-19.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	42.4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	1454	71	339.1	301.6	319.2	39.6	253.5	436.3	324.4	57.5	10.3	25	166.6	165.3	126.3	61.4	37.5	2.8	0.9	0.1	0	0.1	1.8	0.6	5.5	2.2	0.1
balance-sheet.row.total-non-current-liabilities	2141.7	377.8	904.6	904.8	896.5	670	316.6	313.7	130.9	144	114.5	95.6	355	357	119.1	68.3	305.8	18.5	254.7	1.8	1.7	1.1	3.6	4.9	4.4	1.7	0.2
balance-sheet.row.other-liabilities	0	0	0	0	0	0	19.2	19.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	32.8	32.8	0	0	0	3	0	0	0	0	0	0	0	0	0	30.3	29.3	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	4921.1	1182.2	1247.8	1210.2	1219.8	1133	612.4	777.6	463.4	584.8	618.8	783.3	531.7	569.6	547.7	398.5	363.6	291.2	273.9	16.3	15.5	11.7	12.9	15.7	15.9	6.3	2
balance-sheet.row.preferred-stock	0	0	0	0	0	0	19.2	19.2	10.9	11.1	23.2	45	10.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	2.8	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.6	0.6	0.6	0.6	0.6	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0
balance-sheet.row.retained-earnings	23713.2	6027.1	5042.3	4315	3839.2	3325.2	3434.8	2845.6	2433.5	1719.8	1068.1	728	553.5	249	31.2	-74.7	-78.5	-21.5	-41.4	-115.3	-180.3	-195.4	-185.8	-162.2	-124.9	-49.3	-15.8
balance-sheet.row.accumulated-other-comprehensive-income-loss	-122.7	-12.8	-55.5	-23	-14.2	-14.2	-7.9	-19.6	-16.8	-20.4	-16.7	-13.2	-15	-10.9	-9.2	-4.3	-5.9	0.3	1.5	3.6	2.7	1.7	0	-1.4	-0.5	-0.2	0
balance-sheet.row.other-total-stockholders-equity	-1147.3	-30.2	-190.8	-333.8	-430.5	-531.3	-658.2	-744.1	-566.1	-111.5	190.3	543.8	544.8	709.7	861.3	731.5	591.9	316.7	244.2	386.6	369.1	361.3	357.3	359.7	359.9	102.9	32.5
balance-sheet.row.total-stockholders-equity	22446	5984.8	4796.7	3958.9	3395.2	2780.4	2788.6	2101.8	1862.2	1599.6	1265.6	1304.3	1094.9	948.5	883.9	653	507.7	295.8	204.6	275.1	191.6	167.8	171.7	196.4	234.7	53.6	16.7
balance-sheet.row.total-liabilities-and-stockholders-equity	27367.1	7167	6044.5	5169.1	4615	3913.4	3401	2879.4	2325.6	2184.4	1884.4	2087.6	1626.6	1518.1	1431.6	1051.5	871.3	587	478.6	291.4	207.2	179.5	184.6	212.1	250.6	59.9	18.7
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	22446	5984.8	4796.7	3958.9	3395.2	2780.4	2788.6	2101.8	1862.2	1599.6	1265.6	1304.3	1094.9	948.5	883.9	653	507.7	295.8	204.6	275.1	191.6	167.8	171.7	196.4	234.7	53.6	16.7
balance-sheet.row.total-liabilities-and-total-equity	27367.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	9272.5	3696.2	3193.7	2685.8	2245.9	1515	1189.3	725	30.1	160	420.6	863.1	636.3	589.8	512.9	317.7	252.6	53.9	75.4	65.5	56.4	0	10	116280.7	14.5	33.3	0
balance-sheet.row.total-debt	2200	700	800	800	800	850	250	250	0	5.4	126.5	286.2	275	194.2	304.9	250.6	279.2	250	250	0	0	0.8	1.9	1.9	1.9	1.9	0.3
balance-sheet.row.net-debt	-2434.2	-507.7	-161.2	-94.8	61.3	111.6	-419.2	-455.1	-1023	-826.4	-271.2	7.3	121	31.5	52.7	150.2	149.8	110.7	159	-69.2	-82.6	-67.8	-120.8	-22.4	-199	-16.4	-6.5

现金流量表

在 United Therapeutics Corporation 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 0.126 的转变。该公司最近通过发行 6.6 扩大了股本，与上一年相比出现了0.000 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-719600000.000. 与上一年相比， -0.113 发生了变化. 在同一时期，公司记录了 53.2, -23 和 -100，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-98 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 193.3，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	1050.5	984.8	727.3	475.8	514.8	-104.5	589.2	417.9	713.7	651.6	340.1	174.6	304.4	217.9	105.9	19.5	-42.8	19.9	74	65	15.4	-10	-23.7	-37.3	-75.6	-33.5	-12.8
cash-flows.row.depreciation-and-amortization	54.9	53.2	51.3	49.9	49.9	45.9	35.9	31	31.6	32.9	32.2	31.3	27.1	20.5	17.9	11.4	4.5	1	1.5	2.4	2.3	2.3	3.1	3.5	-0.1	-1.3	0
cash-flows.row.deferred-income-tax	71	3.6	-71.7	-89.7	-168.1	-82.7	-104.3	0	0	0	0	0	0	-197.6	41.9	-1	-31.2	-3.3	-37	-18.1	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	51.5	39.1	106.8	138.5	163.8	45.4	-26.4	73.5	12.1	280.3	190.1	320.8	30.1	-15.7	113.9	101	28.7	-29.6	-10.8	18.1	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-219.9	-97.8	-35.1	-48.8	4.3	37.3	130.7	-83.2	-46.2	-37.3	-56.7	-22.4	-29.9	-111.3	-74.8	-53.4	10.7	-5.8	-3.2	-7.5	1.4	-3.1	-13.1	-7.2	1.7	1.8	1.2
cash-flows.row.account-receivables	-172.7	-58.5	-21.7	-41.3	-6	24.4	121.4	-82.7	-21.7	-30.5	-35.7	-10	-24	-16.2	-23.5	-22	-2.3	-4	-8.9	-0.2	0	0	-8.3	-196.7	0	0	0
cash-flows.row.inventory	-20.4	-13.6	-13.4	-7.5	10.3	12.9	9.3	-0.5	-24.5	-6.8	-21	-12.4	-5.9	-16.1	-9.2	-9.1	-2.6	-2.3	-1	-3.5	-0.4	-1.2	-1.9	-4	-2.1	0	0
cash-flows.row.account-payables	61.3	57.1	150.6	112.9	-16.8	-16.3	0	0	0	0	0	0	0	16.7	-2.7	-3.6	18.5	-1.1	-1.1	-2.1	0	0	-3.4	1825.5	0	0	0
cash-flows.row.other-working-capital	-123.8	-82.8	-150.6	-112.9	16.8	16.3	0	0	0	0	0	0	0	-95.7	-39.4	-18.7	-2.9	1.6	7.7	-1.7	1.8	-1.9	0.4	-1632	3.9	1.8	0
cash-flows.row.other-non-cash-items	-313.1	-4.9	23.9	72.5	191	-148	153.3	25.3	-101.7	-301.7	-17	219.4	-8	336.3	6.6	20.2	-19.1	66.9	27.4	-16.2	1.6	2.1	11.4	2.1	42.8	9.3	2
cash-flows.row.net-cash-provided-by-operating-activities	979.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-227.3	-230.4	-138.8	-120.8	-59.3	-83.7	-184.4	-86.3	-38	-49.8	-47.4	-31.9	-111.9	-36	-18.6	-95.4	-124.4	-38.7	-15.6	-6.1	-5.2	-7	-3.6	-0.7	-0.6	-2.3	-1
cash-flows.row.acquisitions-net	326.7	-89.2	7.1	366.1	681.6	-20.5	0	0	0	0	0	0	0	-3.5	0	1.2	-266.1	-260.9	-32.4	0	0.8	0	0	0	-8.1	0	0
cash-flows.row.purchases-of-investments	-2154.1	-2514.3	-1708.6	-1895.3	-2308.8	-1279.5	0	0	0	0	0	0	0	-815.7	-662.2	-310.6	-346	-302	-207.2	-78.1	-37.5	-44.7	-11.2	-152.5	-56.7	-114.3	-10.5
cash-flows.row.sales-maturities-of-investments	1902.9	2137.3	1025.3	1529.2	1627.2	1040.3	0	0	0	0	0	0	0	733.9	457.7	249.1	297.9	318.9	118.8	12.9	30	0	140.6	18.4	76.5	92.6	0
cash-flows.row.other-investing-activites	388.6	-23	3.5	-366.1	-679.2	8	-636.2	-749.3	86.3	553.4	385.9	-263.1	-51.5	0	13.9	-4.8	266.1	260.9	32.4	0	-1	4.2	-5.4	0	-3.9	-0.1	0
cash-flows.row.net-cash-used-for-investing-activites	236.8	-719.6	-811.5	-486.9	-738.5	-335.4	-820.6	-835.6	48.3	503.6	338.5	-295	-163.4	-121.3	-209.2	-160.5	-172.5	-21.7	-104	-71.3	-12.9	-47.5	120.4	-134.8	7.2	-24.1	-11.5
cash-flows.row.debt-repayment	-100	-100	-800	0	-50	-200	-250	0	-8.8	-133.2	-177.8	-1.3	-1	-251	-31.4	0	0	-59.2	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-issued	43.7	6.6	94.3	55.6	38.5	14	0	0	0	0	0	0	0	27.3	0	0	150	58.3	14.4	15	7.1	4.1	0.2	0	210.6	58.4	22.9
cash-flows.row.common-stock-repurchased	-1000.3	-13.8	-11.4	-10.8	-3.7	-2.1	0	-250	-500	-394.5	-483.1	-42.4	-188	0	0	0	0	-67.1	-193.1	0	0	0	0	-2.8	-4.1	0	0
cash-flows.row.dividends-paid	0	-98	-94.3	0	-38.5	-14	0	0	0	0	0	0	0	0	0	0	0	-29.6	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	-40.1	193.3	886.8	-10.8	36.8	813.3	256.3	43.3	-497.7	-447	-576.6	-5.1	-169.1	5.7	178.2	36.5	63	118.4	252.8	-0.8	-0.8	-2.1	-0.1	-0.1	0.1	0.9	0
cash-flows.row.net-cash-used-provided-by-financing-activities	-1128.5	-11.9	75.4	44.8	-16.9	611.2	6.3	43.3	-497.7	-447	-576.6	-5.1	-169.1	-218.1	146.8	36.5	213	20.9	74.1	14.2	6.3	2	0.2	-2.9	206.6	59.3	22.9
cash-flows.row.effect-of-forex-changes-on-cash	0	0	0	0	0	0	0	0.2	-3	-5.3	-3.8	-0.3	0.2	-0.3	2.8	-2.7	-1.2	0	0	0	0	0	0	0	0	0	21.1
cash-flows.row.net-change-in-cash	88	246.5	66.4	156.1	0.3	69.2	-35.9	-317.9	191.2	434.1	113.4	124.9	-8.6	-89.5	151.8	-29.1	-9.9	48.3	21.9	-13.4	14.2	-54.1	98.3	-176.6	182.7	11.5	22.9
cash-flows.row.cash-at-end-of-period	4634.2	1207.7	961.2	894.8	738.7	738.4	669.2	705.1	1023	831.8	397.7	278.9	154	162.7	252.2	100.4	129.5	139.3	91.1	69.2	82.6	68.6	122.7	24.4	200.9	18.3	27.9
cash-flows.row.cash-at-beginning-of-period	4546.2	961.2	894.8	738.7	738.4	669.2	705.1	1023	831.8	397.7	284.3	154	162.7	252.2	100.4	129.5	139.3	91.1	69.2	82.6	68.4	122.7	24.4	200.9	18.3	6.8	5
cash-flows.row.operating-cash-flow	979.7	978	802.5	598.2	755.7	-206.6	778.4	474.2	643.6	382.8	355.3	425.3	323.6	250.2	211.5	97.6	-49.2	49.1	51.8	43.7	20.8	-8.6	-22.3	-38.9	-31.1	-23.7	-9.6
cash-flows.row.capital-expenditure	-227.3	-230.4	-138.8	-120.8	-59.3	-83.7	-184.4	-86.3	-43.2	-49.8	-47.4	-31.9	-111.9	-36	-18.6	-95.4	-124.4	-38.7	-15.6	-6.1	-5.2	-7	-3.6	-0.7	-0.6	-2.3	-1
cash-flows.row.free-cash-flow	752.4	747.6	663.7	477.4	696.4	-290.3	594	387.9	600.4	333	307.8	393.4	211.7	214.2	192.9	2.2	-173.6	10.4	36.1	37.6	15.6	-15.6	-25.8	-39.6	-31.8	-26	-10.6

利润表行

United Therapeutics Corporation 的收入与上期相比变化了 0.202%。据报告, UTHR 的毛利润为 2070。该公司的营业费用为 885.1，与上年相比变化了 9.285%. 折旧和摊销费用为 53.2，与上一会计期间相比变化了 9.640%. 营业费用报告为 885.1，显示9.285% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长0.209%. 营业收入为 1184.9，与上年相比变化了0.209%. 净利润的变化率为 0.354%。去年的净收入为984.8.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
income-statement-row.row.total-revenue	2498.3	2327.5	1936.3	1685.5	1483.3	1448.8	1627.8	1725.3	1598.8	1465.8	1288.5	1117	916.1	743.2	603.8	369.8	281.5	210.9	159.6	115.9	73.6	53.3	30.1	5.7	2	0.4	0.1
income-statement-row.row.cost-of-revenue	278.1	257.5	146.7	122.5	108.1	117.6	198.7	105.7	72.7	69	125.9	131.1	119.3	88.9	73.5	45.3	30.1	22.3	17	12.3	8.3	6.8	5.5	3.1	1.7	1.4	0
income-statement-row.row.gross-profit	2220.2	2070	1789.6	1563	1375.2	1331.2	1429.1	1619.6	1526.1	1396.7	1162.6	985.9	796.8	654.3	530.4	324.5	251.4	188.7	142.6	103.6	65.3	46.6	24.7	2.6	0.3	-1	0.1
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	429.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	324.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	64.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-6.1	-14	-40.2	42.2	49.3	22.6	-7.7	13.2	2.4	0.2	4	0.6	31.9	156.5	199.6	176.3	94.3	99	56.1	24.7	21.5	22.7	15.9	0	-0.1	-1.3	2.4
income-statement-row.row.operating-expenses	961.6	885.1	809.9	1007.1	781.6	1518.8	623.7	594.7	464.4	697.7	623.8	693.4	375.1	336.5	366.4	298.5	333.5	182.4	113.6	60.7	52.1	58.1	42.7	49.5	81.8	34.4	13.4
income-statement-row.row.cost-and-expenses	1239.7	1142.6	956.6	1129.6	889.7	1636.4	822.4	700.4	537.1	766.7	749.7	824.5	494.4	425.4	439.8	343.8	363.6	204.6	130.7	73	60.4	64.9	48.1	52.7	83.5	35.8	13.4
income-statement-row.row.interest-income	187.3	162.7	45.2	16.7	28.6	44.2	28.6	0	0	0	0	3.8	3.9	3.5	2.9	5.1	11	13.6	10.7	5.4	3	2.4	5	10	10.7	0	0
income-statement-row.row.interest-expense	32.2	59.3	32.4	18.6	23.5	44.2	13.9	9	3.9	4.7	17.6	18.1	16.6	21.4	19.7	12.9	0	2.2	0.5	0	0	0.1	0.1	0.2	0.1	0	0
income-statement-row.row.selling-and-marketing-expenses	64.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	36.2	-14	-29.1	38	45.3	22.6	-61.2	-246.4	2.4	350.2	4	0.6	31.7	-0.7	0.6	0.5	-1.3	-1.1	-1.3	-0.7	-0.7	-0.8	-10.5	-0.2	-4.7	0.1	0.5
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-6.1	-14	-40.2	42.2	49.3	22.6	-7.7	13.2	2.4	0.2	4	0.6	31.9	156.5	199.6	176.3	94.3	99	56.1	24.7	21.5	22.7	15.9	0	-0.1	-1.3	2.4
income-statement-row.row.total-operating-expenses	36.2	-14	-29.1	38	45.3	22.6	-61.2	-246.4	2.4	350.2	4	0.6	31.7	-0.7	0.6	0.5	-1.3	-1.1	-1.3	-0.7	-0.7	-0.8	-10.5	-0.2	-4.7	0.1	0.5
income-statement-row.row.interest-expense	32.2	59.3	32.4	18.6	23.5	44.2	13.9	9	3.9	4.7	17.6	18.1	16.6	21.4	19.7	12.9	0	2.2	0.5	0	0	0.1	0.1	0.2	0.1	0	0
income-statement-row.row.depreciation-and-amortization	104	53.2	5	58.9	77.9	66.8	35.9	31	31.6	32.9	32.2	31.3	27.1	20.5	17.9	11.4	4.5	1	1.5	2.4	2.3	2.3	3.1	3.5	-0.1	-1.3	-0.5
income-statement-row.row.ebitda-caps	1411.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	1256.8	1184.9	979.7	555.9	593.6	-187.6	805.4	814.9	1061.7	699	538.8	292.5	421.6	317.8	164	26	-82.1	6.3	29	42.9	13.2	-11.5	-18	-46.9	-81.5	-35.4	-13.3
income-statement-row.row.income-before-tax	1381	1274.3	950.6	593.9	638.9	-165	758.9	769.5	1060.2	1044.4	525.2	278.9	440.7	299.1	147.8	18.8	-72.3	16.6	39.9	47.5	15.4	-10	-23.7	-37.3	-86.2	-35.3	-12.8
income-statement-row.row.income-tax-expense	330.5	289.5	223.3	118.1	124.1	-60.5	169.7	351.6	346.5	392.8	185.1	104.3	136.2	81.9	41.9	-0.7	-29.5	-3.3	-34.1	-17.5	-3	-2.5	5.4	-9.7	-5.9	-1.9	0
income-statement-row.row.net-income	1050.5	984.8	727.3	475.8	514.8	-104.5	589.2	417.9	713.7	651.6	340.1	174.6	304.4	217.9	105.9	19.5	-42.8	19.9	74	65	15.4	-10	-23.7	-37.3	-75.6	-33.5	-12.8